Switching from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution to Tapcom combination ophthalmic solution

2 trials

Sponsors

Inouye Eye Hospital, Kitasato University

Conditions

primary open angle glaucoma or ocular hypertensionprimary open angle glaucoma, normal tension glucoma or ocular hypertension

Unknown Phase

Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.

Active, not recruitingJPRN-UMIN000016052

Inouye Eye Hospitalprimary open angle glaucoma or ocular hypertension

Start: 2014-12-12Target: 30Updated: 2026-06-29

Effects of Tapcom Combination Ophthalmic Solution Switched from Tapros 0.0015% and Timoptol XE 0.5% Solutions

Active, not recruitingJPRN-UMIN000016885

Kitasato Universityprimary open angle glaucoma, normal tension glucoma or ocular hypertension

Start: 2015-03-14Target: 40Updated: 2026-06-29